Harbor Investment Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Harbor Investment Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-460	Closed	-$12.8K	–	1232
2025 Q3	$12.8K	Hold	460	–	–	﹤0.01%	869
2025 Q2	$11.2K	Hold	460	–	–	﹤0.01%	869
2025 Q1	$9.55K	Hold	460	–	–	﹤0.01%	877
2024 Q4	$10.8K	Hold	460	–	–	﹤0.01%	853
2024 Q3	$11.8K	Hold	460	–	–	﹤0.01%	838
2024 Q2	$10.8K	Hold	460	–	–	﹤0.01%	842
2024 Q1	$13.2K	Hold	460	–	–	﹤0.01%	814
2023 Q4	$15.1K	Hold	460	–	–	﹤0.01%	762
2023 Q3	$12.8K	Hold	460	–	–	﹤0.01%	771
2023 Q2	$15.7K	Hold	460	–	–	﹤0.01%	935
2023 Q1	$13.8K	Hold	460	–	–	﹤0.01%	979
2022 Q4	$13K	Hold	460	–	–	﹤0.01%	979
2022 Q3	$15K	Hold	460	–	–	﹤0.01%	958
2022 Q2	$14K	Hold	460	–	–	﹤0.01%	963
2022 Q1	$21K	Hold	460	–	–	﹤0.01%	923
2021 Q4	$28K	Hold	460	–	–	﹤0.01%	876
2021 Q3	$34K	Hold	460	–	–	﹤0.01%	833
2021 Q2	$43K	Hold	460	–	–	0.01%	738
2021 Q1	$41K	Buy	+460	New	+$45.6K	0.01%	723

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Harbor Investment Advisory's ARKG Position: Q4 2025 in Review

Harbor Investment Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 460 shares — an estimated $12.8K sold.

Harbor Investment Advisory first reported a position in ARKG in Q1 2021 and held it in 19 quarters. The position peaked at $43K in Q2 2021. 241 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Harbor Investment Advisory reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Harbor Investment Advisory sold 460 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $12.8K.
Harbor Investment Advisory first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 19 quarters.
Harbor Investment Advisory's ARK Genomic Revolution ETF position peaked at $43K in Q2 2021.
241 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Harbor Investment Advisory's 13F filing for Q4 2025, filed 7 Jan 2026.